Please select the option that best describes you:
Topics:
Neurology • Psychiatry • Behavioral Neurology & Neuropsychiatry • Geriatric Medicine • Dementia
When is it useful to test for multiple amyloid-related biomarkers for patients undergoing work-up for cognitive impairment?
E.g., amyloid PET, CSF amyloid, blood-based amyloid.
Answer from: at Academic Institution
If a patient has a presentation consistent with MCI or early dementia due to AD (slow progressive decline, STM loss, no hallucinations, no neuro deficits), I will get an MRI and amyloid blood-based biomarkers. If the goal is just a diagnosis, I stop there. If they are interested in “mab”...
Sign In or Register to read more